A randomised placebo-controlled trial of combined mitochondrial agents for the treatment of fatigue and depression in multiple sclerosis with an assessment of the impact on kynurenine pathway metabolomics


  • Anne-Louise Ponsonby (Primary Investigator)
  • Simon Broadley (Secondary Investigator)
  • John Christodoulou (Secondary Investigator)
  • Brisa Fernandes (Secondary Investigator)
  • Felice N Jacka (Secondary Investigator)
  • J Lechner-Scott (Secondary Investigator)
  • Emeritus Professor Robyn Lucas (Secondary Investigator)
  • Professor Anne-Louise Ponsonby (Secondary Investigator)
  • B V Taylor (Secondary Investigator)
  • Ingrid Van Der Mei (Secondary Investigator)
  • Damjan Vukcevic (Secondary Investigator)

Grant status


Grant start date


Grant funding

  • 2018: $192,542 from Medical Research Future Fund (MRFF)
  • 2019: $395,544 from Medical Research Future Fund (MRFF)
  • 2020: $298,986 from Medical Research Future Fund (MRFF)

Updated:  29 September 2023 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers